ScienceDaily PharmaceuticalsOriginal article
The Ozempic and Wegovy mistake sending thousands to poison control
RegulatoryOzempicWegovyNegative
AI Analysis
Summary
Poison control calls involving semaglutide (Ozempic and Wegovy) increased following approval for weight management, primarily due to accidental dosing mistakes rather than intentional misuse. Researchers suggest that proper education on weekly dosing schedules and gradual dose escalation could prevent many of these preventable incidents.
Importance:4/10
Sentiment:
-0.60
safetydosing_errorpoison_controlsemaglutidepatient_safetyadverse_events
Related Companies
Read the original article
Published by ScienceDaily Pharmaceuticals on July 9, 2026 4:02 AM
